Craft

Sensus Healthcare

Stock Price

$6.9

2024-10-29

Market Capitalization

$113.9 M

2024-10-29

Revenue

$27.5 M

FY, 2025

Sensus Healthcare Summary

Company Summary

Overview
Sensus Healthcare is focused on making proven non-melanoma skin cancer solutions more accessible to patients. The Company's dedicated Superficial Radiotherapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Sensus' mobile, compact SRT-100 systems are used by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. The Company also offers a professional skin care line, Sensus Skin Solutions, through its physician SRT-100 users for their patients.
Type
Public
Status
Active
Founded
2010
HQ
Boca Raton, FL, US | view all locations
Website
http://sensushealthcare.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Joseph C. Sardano

    Joseph C. Sardano, Chairman and Chief Executive Officer

    • Clay J. Cockerell

      Clay J. Cockerell, Clinical Director

      • Javier Rampolla

        Javier Rampolla, Chief Financial Officer

        • John Heinrich

          John Heinrich, Director

          LocationsView all

          2 locations detected

          • Boca Raton, FL HQ

            United States

            851 Broken Sound Pkwy NW #215

          • Giv'atayim, Tel Aviv District

            Israel

            Ariel Sharon St 4

          Sensus Healthcare Financials

          Summary Financials

          Revenue (FY, 2025)
          $27.5M
          Gross profit (FY, 2025)
          $11.9M
          Net income (FY, 2025)
          ($7.7M)
          Cash (FY, 2025)
          $22.1M
          EBIT (FY, 2025)
          ($10.3M)
          Enterprise value
          $92.3M

          Footer menu